22+ min ago (209+ words) Posted by Mitch Edgeman on Nov 25th, 2025 Wall Street Zen cut shares of X Financial (NYSE:XYF " Free Report) from a buy rating to a hold rating in a research note released on Saturday morning. Separately, Weiss Ratings lowered shares of X Financial from a "buy (b-)" rating to a "hold (c+)" rating in a research report on Wednesday, November 19th. One analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, X Financial presently has a consensus rating of "Hold". Check Out Our Latest Research Report on X Financial X Financial (NYSE:XYF " Get Free Report) last announced its earnings results on Thursday, November 20th. The company reported $1.43 earnings per share (EPS) for the quarter. The company had revenue of $275.45 million for the quarter. X Financial had a return on equity of 24.56% and a net margin of 22.75%. X…...

39+ min ago (112+ words) Posted by Danessa Lincoln on Nov 25th, 2025 Wall Street Zen upgraded shares of Intchains Group (NASDAQ:ICG " Free Report) from a sell rating to a hold rating in a research report sent to investors on Saturday. Check Out Our Latest Stock Report on ICG Intchains Group Limited designs and sells application-specific integrated circuit chips for blockchain applications in the People's Republic of China. The company also offers ancillary software, hardware, and other products. It serves distributors. Intchains Group Limited was founded in 2017 and is based in Pudong, China. ENDRA Life Sciences (NASDAQ:NDRA) Upgraded at Wall Street Zen Sana Biotechnology (NASDAQ:SANA) Cut to Sell at Wall Street Zen...

39+ min ago (206+ words) Posted by Danessa Lincoln on Nov 25th, 2025 Wall Street Zen lowered shares of Curanex Pharmaceuticals (NASDAQ:CURX " Free Report) from a hold rating to a sell rating in a report issued on Saturday morning. Separately, Weiss Ratings initiated coverage on shares of Curanex Pharmaceuticals in a research note on Tuesday, November 18th. They issued a "sell (e-)" rating on the stock. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock currently has a consensus rating of "Sell". Check Out Our Latest Research Report on Curanex Pharmaceuticals Curanex Pharmaceuticals (NASDAQ:CURX " Get Free Report) last released its quarterly earnings results on Friday, November 14th. The company reported ($0.04) earnings per share for the quarter. An institutional investor recently bought a new position in Curanex Pharmaceuticals stock. Citadel Advisors LLC acquired a new stake in Curanex Pharmaceuticals Inc (NASDAQ:…...

39+ min ago (150+ words) Posted by Danessa Lincoln on Nov 25th, 2025 Wall Street Zen upgraded shares of Estrella Immunopharma (NASDAQ:ESLA " Free Report) to a hold rating in a research report released on Saturday. View Our Latest Stock Report on Estrella Immunopharma Estrella Immunopharma (NASDAQ:ESLA " Get Free Report) last posted its quarterly earnings results on Wednesday, November 12th. The company reported ($0.13) EPS for the quarter, beating the consensus estimate of ($0.19) by $0.06. Estrella Immunopharma, Inc, a preclinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States. The company's lead product candidates include EB103 for the treatment of diffuse large B-cell lymphoma and is in pre clinical trial; and EB104 to treat diffuse large B-cell lymphoma and acute lymphocytic leukemia. ENDRA Life Sciences (NASDAQ:NDRA) Upgraded at Wall Street Zen Sana Biotechnology (NASDAQ:SANA) Cut to Sell at Wall Street Zen...

39+ min ago (108+ words) Posted by Mitch Edgeman on Nov 25th, 2025 Wall Street Zen upgraded shares of SCHMID Group (NASDAQ:SHMD " Free Report) to a hold rating in a research report sent to investors on Saturday morning. Separately, Weiss Ratings restated a "sell (e+)" rating on shares of SCHMID Group in a research note on Saturday, September 27th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat.com, SCHMID Group has an average rating of "Sell". Check Out Our Latest Analysis on SCHMID Group ENDRA Life Sciences (NASDAQ:NDRA) Upgraded at Wall Street Zen Sana Biotechnology (NASDAQ:SANA) Cut to Sell at Wall Street Zen...

44+ min ago (176+ words) Posted by Sarita Garza on Nov 25th, 2025 Wall Street Zen upgraded shares of ENDRA Life Sciences (NASDAQ:NDRA " Free Report) to a sell rating in a research note released on Saturday. Separately, Weiss Ratings reissued a "sell (e+)" rating on shares of ENDRA Life Sciences in a research note on Wednesday, October 8th. One research analyst has rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of "Hold" and a consensus price target of $50.00. Check Out Our Latest Research Report on NDRA ENDRA Life Sciences (NASDAQ:NDRA " Get Free Report) last released its earnings results on Friday, November 14th. The company reported ($1.75) earnings per share (EPS) for the quarter, topping the consensus estimate of ($1.95) by $0.20. Equities research analysts anticipate that ENDRA Life Sciences…...

44+ min ago (177+ words) Posted by Kim Johansen on Nov 25th, 2025 Wall Street Zen upgraded shares of Strata Skin Sciences (NASDAQ:SSKN " Free Report) from a sell rating to a hold rating in a report issued on Saturday. Separately, Weiss Ratings reiterated a "sell (e+)" rating on shares of Strata Skin Sciences in a research note on Wednesday, October 8th. One research analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to MarketBeat, Strata Skin Sciences presently has an average rating of "Hold" and a consensus price target of $6.00. Check Out Our Latest Stock Report on Strata Skin Sciences STRATA Skin Sciences, Inc, a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America....

54+ min ago (195+ words) Posted by Kim Johansen on Nov 25th, 2025 Momentus (NASDAQ:MNTS " Get Free Report) was upgraded by equities researchers at Wall Street Zen from a "sell" rating to a "hold" rating in a research report issued to clients and investors on Sunday. Separately, Weiss Ratings restated a "sell (e+)" rating on shares of Momentus in a research report on Wednesday, October 8th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company currently has a consensus rating of "Sell". Read Our Latest Analysis on Momentus Momentus (NASDAQ:MNTS " Get Free Report) last posted its quarterly earnings results on Wednesday, November 19th. The company reported ($1.08) EPS for the quarter. The company had revenue of $0.23 million during the quarter. Momentus Inc, together with its subsidiaries, operates as a commercial space company. The company focuses on providing in-space…...

1+ hour, 11+ min ago (179+ words) Posted by Danessa Lincoln on Nov 25th, 2025 Wall Street Zen cut shares of Regional Management (NYSE:RM " Free Report) from a strong-buy rating to a buy rating in a report released on Saturday. View Our Latest Research Report on RM The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 16th. Investors of record on Tuesday, November 25th will be given a $0.30 dividend. The ex-dividend date of this dividend is Tuesday, November 25th. This represents a $1.20 annualized dividend and a dividend yield of 3.3%. Regional Management's dividend payout ratio (DPR) is currently 29.06%. Regional Management Corp., a diversified consumer finance company, provides various installment loan products primarily to customers with limited access to consumer credit from banks, thrifts, credit card companies, and other lenders in the United States. It offers small and large installment loans; and retail loans to finance the…...

1+ hour, 11+ min ago (65+ words) Posted by Danessa Lincoln on Nov 25th, 2025 Wall Street Zen upgraded shares of Gulfport Energy (NYSE:GPOR " Free Report) from a hold rating to a buy rating in a research note issued to investors on Saturday morning. Get Our Latest Stock Analysis on Gulfport Energy Raymond James Financial Weighs in on CVE:NXL FY2026 Earnings DeFi Technologies (NASDAQ:DEFT) Upgraded at Wall Street Zen...